Gm104 inhibitors are a specific class of small molecules designed to selectively inhibit the activity of the protein encoded by the Gm104 gene. Gm104 belongs to a family of proteins that often participate in key regulatory pathways within cellular processes, including signal transduction and intracellular signaling. These inhibitors are developed with the intent of modulating the protein's function, often through direct binding to its active site or allosteric regions, thereby altering its biological activity. The structure of Gm104 inhibitors typically comprises functional groups capable of forming specific interactions, such as hydrogen bonds, hydrophobic interactions, or van der Waals forces, with the target protein. Such interactions are crucial for achieving high binding specificity and potency toward the Gm104 protein, allowing for a more precise modulation of its biological activity. Additionally, the inhibitors can be fine-tuned to exhibit desired physicochemical properties, such as solubility, stability, and permeability, which are important factors in ensuring effective cellular uptake and optimal engagement with the target protein within the intracellular environment.
The design and optimization of Gm104 inhibitors often involve structural analyses, such as X-ray crystallography or NMR, to characterize how these compounds interact with their target. Such structural insights allow for the rational design of molecules that can improve binding affinity and specificity toward Gm104. Additionally, structure-activity relationship (SAR) studies are integral to optimizing the inhibitory activity, where modifications in the chemical structure of the inhibitor can greatly impact its binding efficiency and selectivity for Gm104 over other related proteins. In biological assays, these inhibitors are evaluated based on their ability to modulate Gm104 activity and their effect on downstream cellular processes. The chemical diversity within this class of inhibitors allows for the fine-tuning of their pharmacological profile, with considerations for selectivity, potency, and functional effects on the target protein. The specificity of Gm104 inhibitors makes them powerful tools for exploring the biological role of Gm104 in different cellular contexts and investigating its broader implications in various molecular pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
Inhibits class III PI3K, which is necessary for autophagosome formation and may indirectly affect Beclin 2 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A broad-spectrum PI3K inhibitor that can suppress autophagy initiation, thereby potentially influencing Beclin 2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that can prevent autophagy induction, potentially affecting Beclin 2's role in this process. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Promotes the degradation of PI3K complex members, which can decrease autophagy and indirectly affect Beclin 2. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Prevents autophagosome-lysosome fusion, which may lead to the accumulation of autophagosomes and indirectly influence Beclin 2. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Similar to Chloroquine, it raises the pH of lysosomes, which can affect autophagosome degradation and Beclin 2 function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits vacuolar-type H+-ATPase, preventing autophagosome-lysosome fusion, potentially impacting Beclin 2. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Disrupts microtubule dynamics, which can inhibit autophagosome transport and indirectly affect Beclin 2 activity. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
Inhibits lysosomal proteases, leading to impaired autophagosome clearance, which may indirectly affect Beclin 2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium homeostasis, which can affect autophagy and thereby influence Beclin 2 activity. | ||||||